» Articles » PMID: 25387578

IL-17A, IL-17F and IL-23R Gene Polymorphisms in Polish Patients with Rheumatoid Arthritis

Overview
Publisher Sciendo
Date 2014 Nov 13
PMID 25387578
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Among the complex network of inflammatory cells involved in the pathogenesis of rheumatoid arthritis (RA), Th17 cells have recently been identified as key cells in the promotion of autoimmune processes, and joint destruction. The IL-23/Th17 signalling pathway, consisting of IL-23/IL-23R, IL-17A and IL-17F encoding genes, represents a candidate way for RA development with possible involvement in disease susceptibility and effect on disease progression. The present study aimed to determine the association between the polymorphic variants of the IL-17A (rs2275913), IL-17F (rs763780) and IL-23R (rs11209026) genes and RA susceptibility, progression and response to therapy with TNF-α inhibitors. Eighty-nine patients and 125 healthy individuals were investigated. The IL-17A polymorphism was found to affect RA progression and response to anti-TNF treatment. Female patients carrying the IL-17A wild-type genotype more frequently presented with stage 4 (8/24 vs. 6/47; p = 0.058) and were characterized by more active disease (the highest DAS28 score >5.1) after 3 months of therapy with the TNF inhibitors (12/23 vs. 15/45; p = 0.040). The IL-17F polymorphism appeared to be associated with susceptibility to the disease. The presence of the IL-17F minor variant (OR 3.97; p < 0.001) and its homozygosity (OR 29.62; p < 0.001) was more frequent among patients than healthy individuals. These results suggest that the polymorphisms within the IL-17A and IL-17F genes play a significant role in RA.

Citing Articles

MiR-223 within neutrophil axis promotes Th17 expansion by PI3K-AKT pathway in systemic lupus erythematosus.

Zhang C, Lu Y Arthritis Res Ther. 2025; 27(1):21.

PMID: 39901260 PMC: 11789401. DOI: 10.1186/s13075-025-03487-x.


Genetic Variants of the IL-23/IL-17 Axis and Its Association With Periodontal Disease: A Systematic Review.

Rodriguez-Montano R, Alarcon-Sanchez M, Lomeli-Martinez S, Martinez-Bugarin C, Heboyan A Immun Inflamm Dis. 2025; 13(2):e70147.

PMID: 39887950 PMC: 11783687. DOI: 10.1002/iid3.70147.


Analysis of IL-17A, IL-17F, and miR-146a-5p Prior to Transplantation and Their Role in Kidney Transplant Recipients.

Wysoczanska B, Dratwa M, Nieszporek A, Niepieklo-Miniewska W, Kaminska D, Ramus T J Clin Med. 2024; 13(10).

PMID: 38792460 PMC: 11122464. DOI: 10.3390/jcm13102920.


Association of Cytokine IL-17, IL-4, IL-6, and IL-12 Gene Polymorphisms in Rheumatoid Arthritis Patients in a Tertiary Care Hospital in Bangladesh.

Jahan T, Saleh A, Anwar S Int J Rheumatol. 2024; 2024:3728179.

PMID: 38344692 PMC: 10857881. DOI: 10.1155/2024/3728179.


Association of IL-17F rs2397084 (E126G), rs11465553 (V155I) and rs763780 (H161R) variants with rheumatoid arthritis and their effects on the stability of protein.

Ali Y, Kausar M, Farooq M, Farooqi N, Islam Z, Khan S PLoS One. 2023; 18(9):e0285874.

PMID: 37751416 PMC: 10522029. DOI: 10.1371/journal.pone.0285874.


References
1.
Miossec P, Korn T, Kuchroo V . Interleukin-17 and type 17 helper T cells. N Engl J Med. 2009; 361(9):888-98. DOI: 10.1056/NEJMra0707449. View

2.
Lubberts E . Th17 cytokines and arthritis. Semin Immunopathol. 2010; 32(1):43-53. PMC: 2836464. DOI: 10.1007/s00281-009-0189-9. View

3.
Paradowska-Gorycka A, Grzybowska-Kowalczyk A, Wojtecka-Lukasik E, Maslinski S . IL-23 in the pathogenesis of rheumatoid arthritis. Scand J Immunol. 2010; 71(3):134-45. DOI: 10.1111/j.1365-3083.2009.02361.x. View

4.
Paradowska-Gorycka A, Wojtecka-Lukasik E, Trefler J, Wojciechowska B, Lacki J, Maslinski S . Association between IL-17F gene polymorphisms and susceptibility to and severity of rheumatoid arthritis (RA). Scand J Immunol. 2010; 72(2):134-41. DOI: 10.1111/j.1365-3083.2010.02411.x. View

5.
Hot A, Zrioual S, Toh M, Lenief V, Miossec P . IL-17A- versus IL-17F-induced intracellular signal transduction pathways and modulation by IL-17RA and IL-17RC RNA interference in rheumatoid synoviocytes. Ann Rheum Dis. 2010; 70(2):341-8. DOI: 10.1136/ard.2010.132233. View